|国家科技期刊平台
首页|期刊导航|浙江医学|基于黏附素HpaA B细胞表位的多抗原肽疫苗的免疫原性鉴定

基于黏附素HpaA B细胞表位的多抗原肽疫苗的免疫原性鉴定OACSTPCD

Preparing a multi-antigen peptide vaccine based on B-cell epitope of Helicobacter pylori adhesin HpaA and determining its immunogenicity

中文摘要英文摘要

目的 制备以幽门螺杆菌(Hp)黏附素HpaA B细胞表位为基础的多抗原肽(MAP)疫苗,并分析其免疫原性.方法 在GenBank数据库检索Hp黏附素HpaA的氨基酸及核苷酸序列.采用表位分析软件预测HpaA的B细胞表位,以此合成8分支MAP并免疫白毛黑眼兔,体外试验测定MAP与兔抗Hp多克隆抗体的亲和力,体内试验检测免疫血清抗体效价和抗体的特异性.结果 HpaA的优势B细胞表位可能位于其氨基酸序列的第130~142和第212~219区段,并分别以上述B细胞表位合成8分支MAP1和MAP2.MAP1和MAP2均能在体外与兔抗Hp多克隆抗体结合,且MAP1具有较高的亲和力.仅MAP1能在体内诱导免疫应答,产生高滴度特异性抗体.结论 HpaA氨基酸序列的第130~142区段为其优势B细胞表位,基于此合成的MAP具有较强的免疫原性.

Objective To prepare a multiple antigenic polypetide(MAP)vaccine based on the B-cell epitope of Helicobacter pylori(Hp)adhesin HpaA and to determine its immunogenicity.Methods Amino acid and nucleotide sequences of HpaA were obtained from GenBank.Epitope analysis softwares were utilized for HpaA B-cell epitope prediction.An 8-branch MAP was synthesized and used to immunize white-haired black eye(WHBE)rabbits.The affinity of MAP and rabbit anti-Hp polyclonal antibodies in vitro was determined,and the serum antibody titer and antibody specificity in vivo were detected.Results The dominant B cell epitopes of HpaA were located in the 130-142 and 212-219 amino acid segments,the 8-branched MAP1 and MAP2 were synthesized according to above B cell epitopes.Both MAP1 and MAP2 showed binding ability to rabbit anti-Hp polyclonal antibodies in vitro,while MAP1 exhibited higher affinity.Only MAP1 induced immune response and produced high-titer specific antibody in vivo.Conclusion The dominant B-cell epitope is located in 130-142 amino acid segment of HpaA,the corresponding MAP was synthesized and the vaccine was prepared in the study,which demonstrates strong immunogenicity.

孙艳;李瑞芳;格桑卓玛;冯明旨;张骏

310014 杭州,浙江省人民医院(杭州医学院附属人民医院)消化内科浙江中医药大学附属第一医院(浙江省中医院)消化内科

幽门螺杆菌黏附素HpaAB细胞表位多抗原肽免疫原性

Helicobacter pyloriAdhesin HpaAB-cell epitopeMulti antigenic polypeptideImmunogenicity

《浙江医学》 2024 (015)

1573-1579,后插1 / 8

浙江省医药卫生重大科技计划项目(WKJ-ZJ-2018);浙江省中医药科技计划项目(2023ZL266)

10.12056/j.issn.1006-2785.2024.46.15.2024-1252

评论